Bryan Yoon
2020 - Terns Pharmaceuticals
In 2020, Bryan Yoon earned a total compensation of $3.2M as Chief Operating Officer, General Counsel and Secretary at Terns Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $57,897 |
|---|---|
| Option Awards | $3,092,836 |
| Salary | $55,500 |
| Total | $3,206,233 |
Yoon received $3.1M in option awards, accounting for 96% of the total pay in 2020.
Yoon also received $57.9K in non-equity incentive plan and $55.5K in salary.
Rankings
In 2020, Bryan Yoon's compensation ranked 3,628th out of 13,090 executives tracked by ExecPay. In other words, Yoon earned more than 72.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,628 out of 13,090 | 72nd |
Division Manufacturing | 1,422 out of 5,620 | 75th |
Major group Chemicals And Allied Products | 536 out of 2,253 | 76th |
Industry group Drugs | 466 out of 1,953 | 76th |
Industry Pharmaceutical Preparations | 352 out of 1,458 | 76th |
Source: SEC filing on April 29, 2022.
Yoon's colleagues
We found two more compensation records of executives who worked with Bryan Yoon at Terns Pharmaceuticals in 2020.
News
Terns Pharmaceuticals CEO Senthil Sundaram's 2022 pay falls 37% to $2M
April 28, 2023
Terns Pharmaceuticals CEO Senthil Sundaram's 2021 pay falls 77% to $3.1M
April 29, 2022
LogicBio Therapeutics CEO Frederic Chereau's 2020 pay jumps 193% to $1.9M
April 27, 2021
LogicBio Therapeutics Senior Vice President, Head of Clinical Development Kenneth Huttner receives $765K in 2019
April 29, 2020